Assessment of the Safety & Efficacy of the Dermal Filler "mARG-01-17" in

Clinical Trial Description

The study is an open-label uncontrolled single-center study for the evaluation of the Performance (efficacy and safety) of the dermal filler "mARG-01-17" in the facial rejuvenation therapy. The design is of a not blinded, not randomized, single group. ;

Study Design

See also
Status	Clinical Trial	Phase
Completed	`NCT03537456` - Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation	N/A
Completed	`NCT02107157` - Clinical and Histological Evaluation of the Picosure 755nm Laser With Cap Array for Facial Rejuvenation	N/A
Completed	`NCT03962621` - A Study of the Efficacy of Erbium:YAG 2940nm in Combination With 1064nm Laser on Facial Rejuvenation	N/A
Completed	`NCT02730650` - Platelet Rich Therapy for Facial Rejuvenation	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT03537456 - Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation

N/A

Completed

NCT02107157 - Clinical and Histological Evaluation of the Picosure 755nm Laser With Cap Array for Facial Rejuvenation

N/A

Completed

NCT03962621 - A Study of the Efficacy of Erbium:YAG 2940nm in Combination With 1064nm Laser on Facial Rejuvenation

N/A

Completed

NCT02730650 - Platelet Rich Therapy for Facial Rejuvenation

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04643977
Study type	Interventional
Source	Mesoestetic Pharma Group S.L.
Contact
Status	Completed
Phase	N/A
Start date	August 30, 2018
Completion date	December 18, 2018

Assessment of the Safety and Efficacy of the Dermal Filler "mARG-01-17" in Facial Rejuvenation Therapy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms